We enrolled a total of @ nondiabetic CKD patients who underwent an @-week treatment with olmesartan from the original trial -LSB- Effects of Low Sodium Intake on the Antiproteinuric Efficacy of Olmesartan in Hypertensive Patients with Albuminuria ( ESPECIAL ) trial : NCT@ -RSB- .